Dr.Vijayakumar TM | Clinical Pharmacy | Best Academic Researcher Award
Department of Pharmacy Practice, SRM College of Pharmacy, India
Author Profile
🌱 Early Academic Pursuits
Dr. T.M. Vijayakumar's journey in the field of pharmacy and healthcare began with a strong academic foundation rooted in Tamil Nadu, India. His Higher Secondary Education (2002) and SSLC Public Examination (2000) results—86.5% and 88.2% respectively—reflect his consistent academic excellence 📚. His passion for pharmacy was further strengthened when he completed his Bachelor of Pharmacy from Annamalai University in 2006 with a commendable OGPA of 8.07. Following this, he pursued his Master of Pharmacy (Pharmacy Practice) at the prestigious J.S.S. College of Pharmacy, where he graduated in 2009 with an impressive 80.5% 🎓.
His academic journey culminated in a Ph.D. (Full-Time) in Pharmacy Practice from SRM College of Pharmacy, SRM Institute of Science and Technology, where he was awarded the distinction of "Highly Recommended Thesis" in 2015. He also successfully completed the AHLS certification from the University of Arizona, USA in 2016 🌎.
👨⚕️ Professional Endeavors
Dr. Vijayakumar’s professional career spans over 13 years and 6 months post-postgraduate experience in academia and research. He serves as the Professor and Head of the Department of Pharmacy Practice at SRM College of Pharmacy, SRM Institute of Science and Technology. His core teaching areas include Pharmacotherapeutics, Clinical Pharmacy Practice, Hospital & Community Pharmacy, and Pharmacoepidemiology and Pharmacoeconomics 💊.
His academic responsibilities go beyond teaching, encompassing research guidance for Pharm.D, B.Pharm, M.Pharm, and Ph.D. scholars, design of patient documentation tools, bedside teaching, and emergency care instruction. Dr. Vijayakumar also leads in health awareness programs, hospital ward round scheduling, and conducting clinical trials in collaboration with both national and international pharmaceutical firms 🏥.
🔬 Contributions and Research Focus
Dr. Vijayakumar is a prolific researcher whose work significantly contributes to the advancement of pharmacy practice in India and globally. He played a pivotal role in a ₹13.5 crore DST-funded project for establishing a National Facility for Clinical Trials. Additionally, he successfully led consultancy-based clinical trials worth ₹37.14 lakhs, partnering with renowned firms like Apex Laboratories, MMC Pharmaceuticals, Himalaya Drug Company, and RedHill Biopharma 💼.
His research article titled “Duration of Seroprotection of the Live Attenuated SA-14-14-2 Japanese Encephalitis Vaccine in Children in India”, published in the Journal of Travel Medicine (Oxford Press), boasts an exceptional impact factor of 39.194, underscoring the relevance of his research in global healthcare 🌐.
Dr. Vijayakumar has also published articles in Nature-indexed journals and collaborated internationally, contributing significantly to the global knowledge pool in pharmaceutical sciences 📈.
🏆 Accolades and Recognition
Dr. Vijayakumar's scholarly excellence and professional integrity have earned him numerous accolades. Notably:
-
Dr. P.D. Sethi Award for Best Research Paper (2020) 🥇
-
Outstanding Reviewer Award from Indian Heart Journal (Elsevier) in 2021 🌟
These recognitions reflect his commitment to quality research, academic peer review, and contribution to medical literature.
🌍 Impact and Influence
Dr. Vijayakumar’s influence extends beyond the academic setting. He established a Drug Information and Patient Counseling Centre at SRM Medical College Hospital and Research Centre, providing crucial pharmaceutical guidance to patients and healthcare professionals alike 💬. Through pharmacovigilance, drug and poison information services, and counseling on drug usage and lifestyle changes, he has directly impacted patient outcomes and public health education.
His mentorship of students and leadership in clinical research trials have positioned him as a key contributor to India’s clinical trial infrastructure and a visionary in pharmacy education 👨🏫.
🔮 Legacy and Future Contributions
Dr. T.M. Vijayakumar is not just a professor but a trailblazer in pharmacy practice. His legacy lies in the students he has mentored, the institutions he has strengthened, and the healthcare systems he continues to innovate. His vision for the future includes advancing clinical pharmacy education, fostering interdisciplinary collaborations, and strengthening India’s global research presence 🌏.
With his ongoing involvement in policy-making, curriculum development, and international research partnerships, Dr. Vijayakumar is set to leave a lasting impact on the next generation of pharmacy professionals and healthcare delivery models in India 🧪👨🔬.
Notable Publications
Title: Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India
Authors: L. Preethi, M. S. Alina, Lakshmi Chandran, S. Asvin, M. Jagadeesan, T. M. Vijayakumar, V. Chitra, Ashok Kumar Pandey, Mahendra M. Reddy, Brij Ranjan Misra, Rajni Kant, Prudhvi Lal Bhukya, Gururaj Rao Deshpande, Priya Abraham, Gajanan Sapkal, Kamran Zaman
Journal: Journal of Travel Medicine, 2022
Title: Functional and Structural Impact of Deleterious Missense Single Nucleotide Polymorphisms in the NR3C1, CYP3A5, and TNF-α Genes: An In Silico Analysis
Authors: Navakanth Raju Ramayanam, Ranjani Manickam, Vijayakumar Thangavel Mahalingam, Khang Wen Goh, Chrismawan Ardianto, Poovi Ganesan, Long Chiau Ming, Rajanandh Muhasaparur Ganesan
Journal: Biomolecules, 2022
Title: Level of adherence to anti-tubercular treatment among drug-sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: A cross-sectional study
Authors: Thamineni R., Peraman R., Chenniah J., Meka G., Munagala A. K., Vijayakumar T. M., Ganesan R. M.
Journal: Tropical Medicine & International Health, 2022
Title: In-silico comparison of cytochrome P450 inhibitory and dopaminergic activity of Piperine, Curcumin and Capsaicin
Authors: Pradeepa B. R., Vijayakumar T. M., Dhivya L. S., Manikandan K.
Journal: Natural Product Research, 2022
Title: NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell line
Authors: Mayuri M., Krishnamurthy P. T., Vijayakumar T. M.
Journal: Experimental and Molecular Pathology, 2022